There is a general agreement in that most of the immune responses decline along with aging (Makinodan et al. 1971 ; Konen et al. 1973 ; Mathies et al. 1973 ; Gerbase-DeLima et al. 1974; Kishimoto et al. 1976 ; Meredith and Walford, 1977) , and the decline is partly correlated ,with reduced thymic functions as manifested by thymic atrophy and decrease in circulating thymic hormones (Lewis et al. 1978 ; Goldstein et al. 1983) . There are numerous studies of trying to restore decreased T cell functions in old mice with thymic hormones (Zatz and Goldstein 1985; Frasca et al. 1985 Frasca et al. , 1986 . In fact thymic hormones can restore cytokine production, such as interleukin-2 (IL-2), colony-stimulating factors, interferon etc., in the senescent mice (Zatz and Goldstein 1985; Frasca et al. 1986 ; Meroni et al. 1987) .
Experimental allergic encephalomyelitis (EAE) is an autoimmune inflammatory disease of the central nervous system, and has been used as an animal model of the human demyelinating disease, multiple sclerosis. We have shown that susceptibility to EAE with bovine proteolipid apoprotein (PLP) is reduced significantly in old mice (Endoh et al. 1990 ). The reduction is caused mainly by the defect of effector T cell functions, which was not restored with exogenous IL-2. Therefore, the present study is an attempt to restore the deReceived June 19, 1990 ; revision accepted for publication July 20, 1990 . 
Antigen and mitogen
Bovine PLP was prepared as described previously (Yoshimura et al. 1985) . Briefly, total crude proteolipid was extracted from brain and spinal cord with chloroform and methanol by Folch's method (Folch et al. 1951) , delipidated, and separated by methylated Sephadex G-100 column chromatography. It was converted to a water-soluble form, and was filtered through a 0.45 a m filter. Purity was confirmed as reported (Yoshimura et al. 1985 ; Satoh et al. 1987 ). Concanavalin A (Con A) was purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Immunization BALB/c mice were immunized on day 0 by abdominal subcutaneous (s.c.) injection of 0.2 ml of an emulsion containing 200 pg of PLP and 50 pg of Mycobacterium tuberculosis (H37Ra ; Difco Laboratories, Detroit, MI, USA) in incomplete Freund's adjuvant. They received a booster s.c. injection of the same emulsion 7 days later. Recipient mice were observed daily for clinical signs of EAE. The severity of EAE was scored as grade 0-5 according to the following criteria : 0, no abnormality ; 1, decreased tail tone or slightly ataxic gait ; 2, clumsy or moderately ataxic gait ; 3, definite weakness of one or more limbs or axial rotating movements ; 4, monoplegia or paraplegia ; 5, a moribund state.
Injection of thymic hormone TF-5 was kindly provided by Dr. Allan L. Goldstein (The George Washington University, Washington D.C.). FTS was purchased from Sigma Chemical Co. Mice were injected i.p. with 500pg of TF-5 or 100 pg of FTS daily starting on the day of challenge with PLP and injection was continued for 11 days to assess in vivo effect of thymic hormone on induction of EAE and on the proliferative response.
In vitro proliferative response
The proliferative response was assessed by [3H1 thymidine (New England Nuclear Corp., Boston, MA, USA) incorporation. Mice were challenged with bovine PLP as described above. Eleven days later, spleens were aseptically removed from donor mice. Single cell suspensions of spleen cells (SPC) were prepared through a 60 pm stainless steel wire mesh in phosphate-buffered saline and washed twice. Red blood cells were removed by osmotic shock. The SPC suspensions were then adjusted to 4 x 106 cells/ml in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY, USA) containing 1% normal mouse serum, 5 x 10-5 M 2-mercaptoethanol, 2 mM L-glutamine,100 U of penicillin per ml, and 100 p g of streptomycin per ml, and they were cultured in the presence of PLP (10 p g/ml) or Con A (1 pg/ml) with or without thymic hormone in flat-bottomed microtiter wells for 96 hr. 37 KBq of [3H] thymidine was added to each well 18 hr before harvest by a semi-automatic multiharvester in a fiberglass filter, and incorporation of [3H] thymidine was measured with a liquid scintillation counter. All determinations were done in triplicate.
RESULTS
In vitro effects of thymic hormone on the proliferative response are shown in Tables 1 and 2 . TF-5 (2-50 ,u g/ml) or FTS (10-50 ,u g/ml) were added at the initiation of culture. They had no obvious effect on in vitro proliferative responses to PLP or Con A in 8-week-old mice and did not restore the reduced proliferative response in 24-month-old mice. In vivo treatment of TF-5 increased proliferative responses to Con A in one experiment using 24-month-old mice. However, the results was statistically insignificant. In vivo treatment with FTS also had no significant effect ( Table 3 ).
The results of the studies of EAE susceptibility by injection of thymic hormones are shown in Table 4 . They had no effect on EAE induction in young and old mice. Thymic hormone-treated mice were observed during the period up to day 188. No significant difference was observed in day of onset and clinical severity between treated and nontreated mice. 
DISCUSSION
Many research groups have recently tried to restore the reduced immune function in the old animals by treatment with thymic hormones. Enhancement of helper and suppressor T cell activity was observed by thymosin al injection (Frasca et al. 1985 (Frasca et al. , 1986 (Frasca et al. , 1987 , and IL-2 production was increased by treatment with thymosin al, TF-5 and thymopentin (Zatz and Goldstein 1985; Frasca et al. 1986; Meroni et al. 1987) . Stimulatory effect of TF-5 on colony-stimulating factor and interferon production was also reported (Zatz and Goldstein 1985) . And treatment of thymosin al augmented antibody production in old mice as well as in young mice (Ershler et al. 1985) .
In the present study we expected to restore the reduced susceptibility to PLP-induced EAE in old BALB/c mice, and we also were hopeful to demonstrate augmentation of in vitro proliferative response to Con A and PLP by treatment with TF-5 and FTS. FTS is known to be an inducer of T-suppressor cells (Back 1979) , and suppression of acute EAE by FTS was reported (Nagai et al. 1982 ; Kato and Nakamura 1988) . But FTS had no effect on induction of EAE in young BALB/c mice. And we have failed to restore the reduced susceptibility to EAE in old mice by treatment with TF-5. These results indicated that these thymic hormones have no augmenting effect on T cell functions when used in young mice, and are insufficient to restore decreased T-cell functions in senescent mice. It seems to be necessary to look for other factors or to use those in combination.
